Digital CRISPR Systems for the Next Generation of Nucleic Acid Quantification

Overview

Journal Trends Analyt Chem

Specialty Chemistry

Date 2023 Feb 6

PMID 36744100

Authors

Anthony J Politza

Reza Nouri

Weihua Guan

Affiliations

Soon will be listed here.

Abstract

Digital CRISPR (dCRISPR) assays are an emerging platform of molecular diagnostics. Digital platforms introduce absolute quantification and increased sensitivity to bulk CRISPR assays. With ultra-specific targeting, isothermal operation, and rapid detection, dCRISPR systems are well-prepared to lead the field of molecular diagnostics. Here we summarized the common Cas proteins used in CRISPR detection assays. The methods of digital detection and critical performance factors are examined. We formed three strategies to frame the landscape of dCRISPR systems: (1) amplification free, (2) in-partition amplification, and (3) two-stage amplification. We also compared the performance of all systems through the limit of detection (LOD), testing time, and figure of merit (FOM). This work summarizes the details of digital CRISPR platforms to guide future development. We envision that improvements to LOD and dynamic range will position dCRISPR as the leading platform for the next generation of molecular biosensing.

Citing Articles

Appraisal of CRISPR Technology as an Innovative Screening to Therapeutic Toolkit for Genetic Disorders.

Shahid A, Zahra A, Aslam S, Shamim A, Ali W, Aslam B Mol Biotechnol. 2025; .

PMID: 39894889 DOI: 10.1007/s12033-025-01374-z.

Control of HSV-1 Infection: Directions for the Development of CRISPR/Cas-Based Therapeutics and Diagnostics.

Sosnovtseva A, Demidova N, Klimova R, Kovalev M, Kushch A, Starodubova E Int J Mol Sci. 2024; 25(22).

PMID: 39596412 PMC: 11595115. DOI: 10.3390/ijms252212346.

CRISPR-based strategies for sample-to-answer monkeypox detection: current status and emerging opportunities.

Ahamed M, Politza A, Liu T, Khalid M, Zhang H, Guan W Nanotechnology. 2024; 36(4).

PMID: 39433062 PMC: 11533882. DOI: 10.1088/1361-6528/ad892b.

Portable wide-field femtoliter-chamber imaging system for point-of-care digital bioanalysis.

Iida T, Ando J, Yoshimura M, Makino A, Nakano M, Kogo Y iScience. 2024; 27(9):110868.

PMID: 39310765 PMC: 11416649. DOI: 10.1016/j.isci.2024.110868.

CRISPR/Cas-Based Techniques for Live-Cell Imaging and Bioanalysis.

Huang S, Dai R, Zhang Z, Zhang H, Zhang M, Li Z Int J Mol Sci. 2023; 24(17).

PMID: 37686249 PMC: 10487896. DOI: 10.3390/ijms241713447.

References

Li S, Cheng Q, Wang J, Li X, Zhang Z, Gao S . CRISPR-Cas12a-assisted nucleic acid detection. Cell Discov. 2018; 4:20. PMC: 5913299. DOI: 10.1038/s41421-018-0028-z. View

Harrington L, Burstein D, Chen J, Paez-Espino D, Ma E, Witte I . Programmed DNA destruction by miniature CRISPR-Cas14 enzymes. Science. 2018; 362(6416):839-842. PMC: 6659742. DOI: 10.1126/science.aav4294. View

Chertow D . Next-generation diagnostics with CRISPR. Science. 2018; 360(6387):381-382. DOI: 10.1126/science.aat4982. View

Kaminski M, Abudayyeh O, Gootenberg J, Zhang F, Collins J . CRISPR-based diagnostics. Nat Biomed Eng. 2021; 5(7):643-656. DOI: 10.1038/s41551-021-00760-7. View

Zhu P, Wang L . Passive and active droplet generation with microfluidics: a review. Lab Chip. 2016; 17(1):34-75. DOI: 10.1039/c6lc01018k. View

Wu X, Tay J, Goh C, Chan C, Lee Y, Springs S . Digital CRISPR-based method for the rapid detection and absolute quantification of nucleic acids. Biomaterials. 2021; 274:120876. DOI: 10.1016/j.biomaterials.2021.120876. View

Schmitz J, Stratton C, Persing D, Tang Y . Forty Years of Molecular Diagnostics for Infectious Diseases. J Clin Microbiol. 2022; 60(10):e0244621. PMC: 9580468. DOI: 10.1128/jcm.02446-21. View

Du W, Li L, Nichols K, Ismagilov R . SlipChip. Lab Chip. 2009; 9(16):2286-92. PMC: 2719824. DOI: 10.1039/b908978k. View

Dube S, Qin J, Ramakrishnan R . Mathematical analysis of copy number variation in a DNA sample using digital PCR on a nanofluidic device. PLoS One. 2008; 3(8):e2876. PMC: 2483940. DOI: 10.1371/journal.pone.0002876. View

10.

Noji H, Minagawa Y, Ueno H . Enzyme-based digital bioassay technology - key strategies and future perspectives. Lab Chip. 2022; 22(17):3092-3109. DOI: 10.1039/d2lc00223j. View

11.

Kannan S, Altae-Tran H, Jin X, Madigan V, Oshiro R, Makarova K . Compact RNA editors with small Cas13 proteins. Nat Biotechnol. 2021; 40(2):194-197. PMC: 8929162. DOI: 10.1038/s41587-021-01030-2. View

12.

Teh S, Lin R, Hung L, Lee A . Droplet microfluidics. Lab Chip. 2008; 8(2):198-220. DOI: 10.1039/b715524g. View

13.

Barrangou R, Doudna J . Applications of CRISPR technologies in research and beyond. Nat Biotechnol. 2016; 34(9):933-941. DOI: 10.1038/nbt.3659. View

14.

Shinoda H, Taguchi Y, Nakagawa R, Makino A, Okazaki S, Nakano M . Amplification-free RNA detection with CRISPR-Cas13. Commun Biol. 2021; 4(1):476. PMC: 8055673. DOI: 10.1038/s42003-021-02001-8. View

15.

Li S, Cheng Q, Liu J, Nie X, Zhao G, Wang J . CRISPR-Cas12a has both cis- and trans-cleavage activities on single-stranded DNA. Cell Res. 2018; 28(4):491-493. PMC: 5939048. DOI: 10.1038/s41422-018-0022-x. View

16.

Li Y, Li S, Wang J, Liu G . CRISPR/Cas Systems towards Next-Generation Biosensing. Trends Biotechnol. 2019; 37(7):730-743. DOI: 10.1016/j.tibtech.2018.12.005. View

17.

Barrangou R, Horvath P . A decade of discovery: CRISPR functions and applications. Nat Microbiol. 2017; 2:17092. DOI: 10.1038/nmicrobiol.2017.92. View

18.

Shang L, Cheng Y, Zhao Y . Emerging Droplet Microfluidics. Chem Rev. 2017; 117(12):7964-8040. DOI: 10.1021/acs.chemrev.6b00848. View

19.

Chen J, Ma E, Harrington L, Da Costa M, Tian X, Palefsky J . CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science. 2018; 360(6387):436-439. PMC: 6628903. DOI: 10.1126/science.aar6245. View

20.

Pinheiro L, Coleman V, Hindson C, Herrmann J, Hindson B, Bhat S . Evaluation of a droplet digital polymerase chain reaction format for DNA copy number quantification. Anal Chem. 2011; 84(2):1003-11. PMC: 3260738. DOI: 10.1021/ac202578x. View